Journal of Multiple Sclerosis

Department of Chemistry, MBPG College, Haldwani, Nainital, India

Publications

• Commentary Article   
  Multiple Sclerosis: An Overview in 2023
  Author(s): Chiranjeev Bisht* and Dakshita Mehra
  
  Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system, characterized by inflammation, demyelination, and axonal damage. Its exact cause remains elusive, but a combination of genetic and environmental factors triggers immune dysregulation, leading to myelin destruction and neurological deficits. MS presents with diverse clinical features, including fatigue, weakness, numbness, visual disturbances, and cognitive impairment. Diagnosed via MRI scans, the disease course can be relapsing-remitting or progressive. Disease-Modifying Therapies (DMTs) and symptomatic management are key treatment approaches. Traditional DMTs, monoclonal antibodies, and emerging therapies hold promise in halting disease progression and promoting functional recovery. Early diagnosis and comprehensive management are crucial for improving patient outcomes and quality of life. Ongoing .. View More»
  DOI: 10.35248/2376-0389.23.10.7.510

  Abstract HTML PDF